Understanding brain and muscle changes in Becker muscular dystrophy
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study uses brain and muscle scans, thinking tests, and muscle assessments to understand how the absence of the Dp140 protein affects people with Becker muscular dystrophy. You may be able to join if you have this condition, can walk, and are interested in helping doctors learn more.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of Becker muscular dystrophy based on genetic testing.
- You are able to walk without assistance.
- You do not have any metal implants or conditions that make MRI unsafe.
- You are not allergic to contrast dye used in some scans.
- You do not have other brain or nerve diseases that could affect the study results.
- You haven't had cancer recently or are not currently on cancer treatment, and your heart and lung function are stable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans and blood or other biomarkers to better understand muscular dystrophy in people with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). It may help researchers track disease changes and identify measurable markers over time.
This study uses a new type of ultrasound scan to look at muscle health in people with Duchenne or Becker muscular dystrophy. It aims to find better ways to track the disease over time.
This study follows women who have a confirmed DMD gene mutation (a genetic change related to Duchenne/Becker muscular dystrophy) to learn more about health and muscle-related measurements. Depending on the part of the study, you may be asked to take part in MRI or other assessments.
This study looks at heart health in people with Duchenne or Becker muscular dystrophy to find better ways to predict and track heart problems. The goal is to improve future treatment trials.
This study uses artificial intelligence to analyze muscle MRI scans in people with genetically confirmed neuromuscular diseases. It aims to improve how these conditions are diagnosed and tracked.
This study collects blood and, for some people, muscle tissue to look for signs (biomarkers) that can help track and better understand myotonic dystrophy. You may help by providing samples and basic muscle function testing, depending on your age and condition type.
Hear when a new Becker Muscular Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.